3rdSympDCEXS

News

30.10.2014
UPF and Aelis Farma sign a licensing agreement for the treatment of dendritic diseases
UPF has assigned the company exclusive rights to develop and market a CB1 cannabinoid receptor antagonist, developed at the CEXS Neuropharmacology Laboratory for the prevention and treatment of diseases such as fragile X and Down syndrome, as well as other possible indications.
28.10.2014
A study reveals a hitherto unknown protein affinity
Coordinated by Gianni Fabritiis researcher ICREA at CEXS Department and head of the laboratory of Computational Biophysics at GRIB (IMIM - UPF), published in Nature Communications on October 28th.
21.10.2014
Arnau Busquets, is awarded a prize by the Spanish Royal Academy of Doctors
Arnau Busquets, a researcher linked to the Neuropharmacology Laboratory headed by professor Rafael Maldonado, of the UPF Department of Experimental and Health Sciences (CEXS), has been awarded the Prize of the Spanish Royal Academy of Doctors in the Life and Health Sciences category, ex aequo 2014 for his thesis: Targeting the endocannabinoid system for Therapeutic Purposes, which he defended on July 4, 2013 and which was supervised by professors Andres Ozaita and Rafael Maldonado.
20.10.2014
Signing of the new Code of Good Scientific Practice
On Wednesday October 5, the directors of the PRBB and the seven research centres located in the park signed their adherence to the new edition of the Code of Good Scientific Practice.
15.10.2014
The new voyage of the 'Argonautes'
A work coordinated by Eduardo Eyras from Pompeu Fabra University and Alberto Kornblihtt from the University of Buenos Aires, describes a new function for a protein mostly characterized for its role in directing small non-coding RNAs to their targets. It is published in 14 october at PNAS.
23.09.2014
A method for predicting biological invasions is developed
An international team of scientists, including Ricard SolÚ, ICREA researcher at the CEXS, has devised a method to quickly and easily predict which exotic species can become invasive populations.
12.09.2014
Sequencing and analysis of gibbon genome sheds light on its complex evolution and the role of repeats in chromosomal rearrangements
Researchers from the Institut de Biologia Evolutiva (CISC-UPF)  and the Centre Nacional d'AnÓlisi Gen˛mica (CNAG) participate in an international consortium to decipher the gibbon genome, which will provide clues for human health research. The study has been published today in the journal Nature.
10.09.2014
Jordi Sunyer, awarded with the "Nobel prize" for environment and health research
Professor in Family Medicine and Preventive Medicine at the University Pompeu Fabra he has obtained the John Goldsmith Award, the most important prize for environmental and health research.
28.07.2014
Josep Eladi Ba˝os, new member of the Management Board at the AQU Catalonia
Professor of Pharmacology at the Department of Experimental and Health Sciences joined this public entity, whose mission is to ensure the quality of higher education in the country, as a outstanding person of academic community.
28.07.2014
Scientists have completed the genome sequence of the marmoset, the first sequence of a New World monkey

A group at the Institute of Evolutionary Biology led by Tomas Marques-Bonet (CSIC-UPF), ICREA researcher at the Department of Experimental and Health Sciences at UPF, has participated in the investigation. The study analysed the genetic characteristics of the farthest branch from humans in the evolutionary tree of primates.

Contact

PRBB building (Mar campus)
Doctor Aiguader, 88
08003 Barcelona

Phone: (+34) 93 316 09 00
Fax: (+34) 93 316 09 01

departament.cexs@upf.edu

 

Highlights

Related websites

Links